Related Experiment Video
Updated: Aug 7, 2026

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus
Published on: June 17, 2015
The various aggregation states of beta-amyloid 1-42 mediate different effects on oxidative stress, neurodegeneration,
Elena Tamagno1, Paola Bardini, Michela Guglielmotto
1General Pathology Section, Department of Experimental Medicine and Oncology, University of Turin, Corso Raffaello 30, 10125 Turin, Italy. elena.tamagno@unito.it
Abstract:
The amyloid cascade hypothesis suggests that the insoluble and fibrillar form of beta-amyloid (A beta) may play a primary pathogenic role in Alzheimer disease at the molecular level. However, neither the rate of dementia nor the extent of neuronal change seems to correlate with the levels of amyloidotic plaques (i.e., aggregated/fibrillar A beta). Recent evidence suggests, however, that neurotoxicity may be exerted also by rather small soluble aggregates of A beta, including oligomers. To characterize the mechanisms underlying toxicity mediated by the various aggregation states of A beta peptides is then a major goal of research. In this work we investigated the effects of fibrillar, prefibrillar, and oligomeric A beta(1-42) on the induction of oxidative stress, cell death, and BACE-1 expression in NT2 neuronal cells. We found that prefibrillar and oligomeric A beta(1-42) resulted in a more dramatic increase in the oxidative stress markers 4-hydroxynonenal and hydrogen peroxide compared to fibrillar A beta(1-42). Moreover, increased oxidative stress levels also resulted in a more rapid and significant induction of both apoptotic and necrotic neuronal cell death. Accordingly, fibrillar A beta(1-42), but not the soluble nonfibrillar forms, was the only condition able to up-regulate BACE-1 expression and activity.
Insights
Soluble beta-amyloid (A beta) oligomers and prefibrillar forms cause significant oxidative stress and neuronal death in Alzheimer disease models. Fibrillar A beta, however, uniquely increases BACE-1 expression.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- The amyloid cascade hypothesis implicates beta-amyloid (A beta) plaques in Alzheimer disease pathogenesis.
- Correlation between plaque load and dementia severity is weak, suggesting other A beta species may be toxic.
- Soluble A beta oligomers are increasingly recognized as potent neurotoxic agents.
Purpose of the Study:
- To investigate the differential neurotoxic effects of fibrillar, prefibrillar, and oligomeric A beta(1-42) species.
- To characterize the impact of these A beta forms on oxidative stress, neuronal cell death, and BACE-1 activity.
Main Methods:
- Exposure of NT2 neuronal cells to distinct A beta(1-42) aggregation states (fibrillar, prefibrillar, oligomeric).
- Measurement of oxidative stress markers (4-hydroxynonenal, hydrogen peroxide).
- Assessment of apoptotic and necrotic cell death.
- Quantification of BACE-1 expression and activity.
Main Results:
- Prefibrillar and oligomeric A beta(1-42) induced significantly higher levels of oxidative stress markers compared to fibrillar A beta(1-42).
- Elevated oxidative stress correlated with accelerated apoptotic and necrotic neuronal cell death.
- Only fibrillar A beta(1-42) significantly upregulated BACE-1 expression and activity.
Conclusions:
- Soluble, non-fibrillar A beta species (oligomers and prefibrillar forms) are potent inducers of oxidative stress and neuronal death.
- Fibrillar A beta exhibits distinct effects, primarily upregulating BACE-1, suggesting different roles in Alzheimer disease.
- These findings highlight the complex and differential roles of A beta aggregation states in Alzheimer disease pathology.
More Related Videos
11:04Evaluation of the Impact of Protein Aggregation on Cellular Oxidative Stress in Yeast
Published on: June 23, 2018
09:52Modified Roller Tube Method for Precisely Localized and Repetitive Intermittent Imaging During Long-term Culture of Brain Slices in an Enclosed System
Published on: December 28, 2017
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology